Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution

Qing Dai(Howard Hughes Medical Institute), Lisheng Zhang(Howard Hughes Medical Institute), Hui‐Lung Sun(Howard Hughes Medical Institute), Kinga Pajdzik(Howard Hughes Medical Institute), Lei Yang(Shanghai First Maternity and Infant Hospital), Chang Ye(Howard Hughes Medical Institute), Cheng‐Wei Ju(Howard Hughes Medical Institute), Shun Liu(Howard Hughes Medical Institute), Yuru Wang(Howard Hughes Medical Institute), Zhong Zheng(Howard Hughes Medical Institute), Linda Zhang(Howard Hughes Medical Institute), Bryan T. Harada(Howard Hughes Medical Institute), Xiaoyang Dou(Howard Hughes Medical Institute), Iryna Irkliyenko(University of Chicago), Xinran Feng(Howard Hughes Medical Institute), Wen Zhang(University of Chicago), Tao Pan(University of Chicago), Chuan He(Howard Hughes Medical Institute)
Nature Biotechnology
October 27, 2022
Cited by 235Open Access
Full Text

Abstract

Functional characterization of pseudouridine (Ψ) in mammalian mRNA has been hampered by the lack of a quantitative method that maps Ψ in the whole transcriptome. We report bisulfite-induced deletion sequencing (BID-seq), which uses a bisulfite-mediated reaction to convert pseudouridine stoichiometrically into deletion upon reverse transcription without cytosine deamination. BID-seq enables detection of abundant Ψ sites with stoichiometry information in several human cell lines and 12 different mouse tissues using 10-20 ng input RNA. We uncover consensus sequences for Ψ in mammalian mRNA and assign different 'writer' proteins to individual Ψ deposition. Our results reveal a transcript stabilization role of Ψ sites installed by TRUB1 in human cancer cells. We also detect the presence of Ψ within stop codons of mammalian mRNA and confirm the role of Ψ in promoting stop codon readthrough in vivo. BID-seq will enable future investigations of the roles of Ψ in diverse biological processes.


Related Papers